The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II trial of modified (m) FOLFOX6 induction chemotherapy with or without aflibercept before standard chemoradiotherapy (CRT) and total mesorectal excision (TME) in patients with high-risk rectal adenocarcinoma (HRRC): Final results of the GEMCAD 1402, and by molecular subtypes.
 
Carlos Fernandez-Martos
Consulting or Advisory Role - SERVIER
Research Funding - Amgen; Sanofi
Travel, Accommodations, Expenses - Amgen; Roche
Other Relationship - Amgen; Celgene; Sanofi; servier
 
Isidro Machado
No Relationships to Disclose
 
Carles Pericay
No Relationships to Disclose
 
Nuria Salas
No Relationships to Disclose
 
Jaime Feliu Batlle
No Relationships to Disclose
 
Sanne ten Hoorn
No Relationships to Disclose
 
Louis Vermeulen
No Relationships to Disclose
 
Ferran Losa
No Relationships to Disclose
 
Rocio Garcia Carbonero
No Relationships to Disclose
 
Vicente Alonso
Consulting or Advisory Role - Amgen; Ipsen; Sanofi/Regeneron; SERVIER
Travel, Accommodations, Expenses - Amgen; Ipsen; Merck Serono; Novartis; Roche; Sanofi/Regeneron; SERVIER
 
Ruth Vera
No Relationships to Disclose
 
Javier Gallego
No Relationships to Disclose
 
Jaume Capdevila
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Eisai; Exelixis; Ipsen; Merck Serono; Novartis; Pfizer; Sanofi
Speakers' Bureau - Bayer; Eisai; Ipsen; Merck Serono; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Ipsen (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Eisai; Ipsen; Pfizer
 
Antonieta Salud
No Relationships to Disclose
 
Miguel Nogué
No Relationships to Disclose
 
Joan Maurel
No Relationships to Disclose
 
Laura Layos
No Relationships to Disclose
 
Clara Montagut
No Relationships to Disclose
 
Xabier Garcia-Albeniz
No Relationships to Disclose